Hokkaido University And Hitachi, Ltd. Complete A Facility Incorporating A Novel Proton Beam Therapy System For Cancer Treatment Developed Jointly Under Japan’s FIRST Program

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAPPORO, Japan--(BUSINESS WIRE)--Hokkaido University and Hitachi, Ltd. (TSE:6501) today announced that they have completed construction of facilities incorporating the “PROBEAT-RT Proton Beam Therapy System,” a novel proton beam cancer treatment system, within the Hokkaido University Hospital. Hokkaido University and Hitachi had been jointly developing the PROBEAT-RT after the project was awarded a grant in 2010 under the Funding Program for World-Leading Innovative R&D on Science and Technology (the “FIRST Program”), a national project sponsored by the Japanese government. The University plans to begin treatments using the newly constructed facilities on March 19, 2014.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC